Blood Coagulation Factors Concept

subject area of

• A 23bp Insertion in the Endothelial Protein C Receptor (EPCR) Gene Impairs EPCR Function  Journal Articles
• A comparison of the quantitative ristocetin von willebrand factor assay by using fresh and fixed platelets  Journal Articles
• A survey of patients with haemophilia to understand how they track product used at home  Journal Articles
• Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus  Journal Articles
• Acute Hepatic Necrosis and Ischemic Limb Necrosis  Journal Articles
• Acute Thrombocytopenia and Thrombosis  Journal Articles
• Altered preoperative coagulation and fibrinolysis are associated with myocardial injury after non-cardiac surgery  Journal Articles
• An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.  Journal Articles
• An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect  Journal Articles
• An open clinical study assessing the efficacy and safety of Factor IX Grifols, a high-purity Factor IX concentrate, in patients with severe haemophilia B.  Journal Articles
• Analysis of Inhibition Rate Enhancement by Covalent Linkage of Antithrombin to Heparin as a Potential Predictor of Reaction Mechanism  Journal Articles
• Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis  Journal Articles
• Anticoagulants in pregnancy: A review of indications and complications  Journal Articles
• Antithrombin-Independent Anticoagulation by Hypersulfated Low-Molecular-Weight Heparin  Journal Articles
• Bile acids and coagulation factors  Journal Articles
• Bivalirudin, thrombin and platelets: clinical implications and future directions.  Journal Articles
• Bleeding and antidotes in new oral anticoagulants  Journal Articles
• Bleeding disorders in neonates  Journal Articles
• C-Reactive Protein as a Screening Test for Cardiovascular Risk in a Multiethnic Population  Journal Articles
• Can evidence harm? Certainly not hemophilia treatment and community  Journal Articles
• Challenging the 30‐min rule for thawed plasma  Journal Articles
• Changes in coagulation factor activity and content of di(2‐ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing  Journal Articles
• Chemistry, Measurement, and Clinical Significance of Platelet Specific Proteins  Journal Articles
• Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia.  Journal Articles
• Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes  Journal Articles
• Clotting factor concentrate switching and inhibitor development in hemophilia A  Journal Articles
• Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B  Journal Articles
• Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B  Journal Articles
• Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B  Journal Articles
• Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B  Journal Articles
• Coagulation Disorders and Blood Product Use in Patients Undergoing Thoracoabdominal Aortic Aneurysm Repair  Journal Articles
• Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass  Journal Articles
• Coagulation factor concentrates by continuous infusion  Journal Articles
• Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis  Journal Articles
• Coagulopathy in a patient with nephrotic syndrome  Journal Articles
• Colloid Transfusion, Natural Anticoagulant Depletion, and Symmetric Peripheral Gangrene  Journal Articles
• Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”  Journal Articles
• Comparative effects of heparin and LMW heparin on hemostasis  Conferences
• Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers  Journal Articles
• Continuous Infusion of Factor Concentrates: Review of Use in Hemophilia A and Demonstration of Safety and Efficacy in Hemophilia B  Conferences
• Continuous infusion  Conferences
• Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time  Journal Articles
• Coping Style in Relation to the Consumption of Factor Concentrate in HIV-Infected Hemophiliacs during the Years after Their Infection Became Known  Journal Articles
• Correlation of Plasma Coagulation Parameters With Thromboprophylaxis, Patient Characteristics, and Outcome in the MEDENOX Study  Journal Articles
• Current anticoagulant therapy—unmet clinical needs  Conferences
• DDAVP—The Multipotent Drug in Patients With Coagulopathies  Journal Articles
• Detection of a Platelet-Agglutinating Factor in Thrombotic Thrombocytopenic Purpura  Journal Articles
• Developing a tracking system for coagulation factor concentrates in southern Ontario  Journal Articles
• Development of the human coagulation system in the full-term infant  Journal Articles
• Development of the human coagulation system in the healthy premature infant  Journal Articles
• Diagnosis and treatment of intracranial hemorrhage in children with hemophilia  Journal Articles
• Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding  Journal Articles
• EFFECT OF SERA ON THROMBIN ACTIVATION RATE CONSTANTS: A ONE‐STAGE ASSAY OF THE EXTRINSIC SYSTEM  Journal Articles
• EPIDEMIOLOGY AND PATHOGENESIS OF VENOUS THROMBOSIS  Journal Articles
• Effect of RA233 on Platelet Function In Vitro  Journal Articles
• Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia.  Journal Articles
• Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA.  Journal Articles
• Effectin vitroon platelet function of two compounds developed from the pyrimido-pyrimidines  Journal Articles
• Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events  Journal Articles
• Effects of the chemotherapeutic agent doxorubicin on the protein C anticoagulant pathway  Journal Articles
• Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation  Journal Articles
• Emicizumab state‐of‐the‐art update  Journal Articles
• Endogenous protein C activation in patients with severe sepsis  Journal Articles
• Epidemiology and pathogenesis of venous thrombosis  Journal Articles
• EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis  Journal Articles
• Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study  Journal Articles
• Exchange of albumin adsorbed on polymer surfaces.  Journal Articles
• Factors XI and XII are low in subjects with liver disease  Journal Articles
• Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia  Journal Articles
• First analysis of 10‐year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management System  Journal Articles
• Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding  Journal Articles
• Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors  Journal Articles
• Fusion to Human Serum Albumin Extends the Circulatory Half-Life and Duration of Antithrombotic Action of the Kunitz Protease Inhibitor Domain of Protease Nexin 2  Journal Articles
• Global data and haemophilia care trends: commentary  Journal Articles
• Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors  Journal Articles
• Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course--the Kogeniale project.  Journal Articles
• Haemophilia care – past, present and future from a patient perspective  Journal Articles
• Haemophilia prophylaxis: how can we justify the costs?  Journal Articles
• Haemorrhagic and Thromboembolic Complications versus Intensity of Treatment of Venous Thromboembolism with Oral Anticoagulants  Journal Articles
• Haemorrhagic and thromboembolic complications versus intensity of treatment of venous thromboembolism with oral anticoagulants.  Journal Articles
• Handheld computers and paper diaries for documenting the use of factor concentrates used in haemophilia home therapy: a qualitative study  Journal Articles
• Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy  Journal Articles
• Hemostasis and atherosclerosis.  Journal Articles
• Heparin/Heparan Sulfate (HP/HS) Interacting Protein (HIP) Supports Cell Attachment and Selective, High Affinity Binding of HP/HS  Journal Articles
• Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs  Journal Articles
• How I treat target-specific oral anticoagulant–associated bleeding  Journal Articles
• How can we reverse bleeding in patients on direct oral anticoagulants?  Journal Articles
• Hypercoagulability.  Journal Articles
• Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients  Journal Articles
• IMMUNOMODULATORY EFFECT OF THE TREATMENT OF GRAVES’DISEASE ON ANTIGEN‐SPECIFIC MONOCYTE PROCOAGULANT ACTIVITY PRODUCTION  Journal Articles
• Identification of proteins adsorbed to hemodialyser membranes from heparinized plasma  Journal Articles
• Identification of the Protein C/Activated Protein C Binding Sites on the Endothelial Cell Protein C Receptor  Journal Articles
• Impact of Arterial Procedures on Coagulation and Fibrinolysis – A Pilot Study  Journal Articles
• Impaired Fibrinolytic Activity Is Present in Children with Dyslipidemias  Journal Articles
• Infection-Induced Thrombocytopenia  Journal Articles
• Intensive Initial Oral Anticoagulation and Shorter Heparin Treatment in Deep Vein Thrombosis  Journal Articles
• Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin  Journal Articles
• Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors  Journal Articles
• Joint WFH‐ISTH session: issues in clinical trial design  Journal Articles
• Joint Bleeding Tendencies in Adult Patients With Hemophilia: It’s Not All Pharmacokinetics  Journal Articles
• Laboratory abnormalities in thrombotic thrombocytopenic purpura  Journal Articles
• Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group.  Journal Articles
• Management of bleeding with oral anticoagulants in patients with atrial fibrillation  Journal Articles
• Management of direct factor Xa inhibitor–related major bleeding with prothrombin complex concentrate: a meta-analysis  Journal Articles
• Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report  Journal Articles
• Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study  Journal Articles
• Massive transfusion  Journal Articles
• Maturation of the hemostatic system during childhood  Journal Articles
• Mechanisms by Which Soluble Endothelial Cell Protein C Receptor Modulates Protein C and Activated Protein C Function  Journal Articles
• Monitoring the anticoagulant effect after a massive rivaroxaban overdose  Journal Articles
• More on: are randomized clinical trials the only truth? Not always  Journal Articles
• Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate  Journal Articles
• New Concepts in Coagulation  Journal Articles
• New anticoagulant drugs.  Journal Articles
• New anticoagulants  Conferences
• New developments in laboratory diagnosis and monitoring  Journal Articles
• New oral anticoagulants: A view from the laboratory  Journal Articles
• Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B  Journal Articles
• Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel  Journal Articles
• Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial  Journal Articles
• Optimal reversal of vitamin K antagonists  Journal Articles
• Oral surgery in patients with hereditary bleeding disorders  Journal Articles
• Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials  Journal Articles
• Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care  Journal Articles
• Orthotopic liver transplantation in a patient with combined hemophilia A and B  Journal Articles
• Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes  Journal Articles
• Patients’, physicians’, and pharmacists’ preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study  Journal Articles
• Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH  Journal Articles
• Placental Barrier to Coagulation Factors: Its Relevance to the Coagulation Defect at Birth and to Haemorrhage in the Newborn  Journal Articles
• Plasma-derived biological medicines used to promote haemostasis  Journal Articles
• Platelet factor V New York: A defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation  Journal Articles
• Platelet-Aggregating Factor in Thrombotic Thrombocytopenic Purpura  Journal Articles
• Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants  Journal Articles
• Praktische Behandlung der Warfarin-assoziierten Gerinnungsstörung  Journal Articles
• Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized  Journal Articles
• Prolonged hemorrhagic shock does not impair regeneration of plasma coagulant masses in the rabbit  Journal Articles
• Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature  Journal Articles
• Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma  Journal Articles
• Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study  Journal Articles
• Prothrombin Complex Concentrates for Intracranial Hemorrhage on Factor Xa Inhibitors  Journal Articles
• Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non–vitamin K Anticoagulant Reversal  Journal Articles
• Prothrombin complex concentrate (PCC, Octaplex®) in patients requiring immediate reversal of vitamin K antagonist anticoagulation  Journal Articles
• Prothrombin complex concentrate for direct factor Xa inhibitor-associated bleeding or before urgent surgery.  Journal Articles
• Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors  Journal Articles
• Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study  Journal Articles
• Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis  Journal Articles
• Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy  Journal Articles
• Rapid reversal of haematoma expansion associated with vitamin K antagonists  Journal Articles
• Rare bleeding disorders: Advances in management  Journal Articles
• Rare inherited coagulation and fibrinolytic defects that challenge diagnostic laboratories  Journal Articles
• Recent Advances in Antidotes for Direct Oral Anticoagulants: Their Arrival Is Imminent  Journal Articles
• Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors  Journal Articles
• Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura  Journal Articles
• Reversal of New, Factor-specific Oral Anticoagulants by rFVIIa, Prothrombin Complex Concentrate and Activated Prothrombin Complex Concentrate: A Review of Animal and Human Studies  Journal Articles
• Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study  Journal Articles
• Reversing Anticoagulant Therapy  Journal Articles
• Reversing anticoagulants both old and new.  Journal Articles
• Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers  Journal Articles
• Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists  Journal Articles
• Sensitization of T lymphocytes to thyroid antigen in autoimmune thyroid disease as demonstrated by the monocyte procoagulant activity test  Journal Articles
• Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia  Journal Articles
• Serum-induced platelet procoagulant activity: An assay for the characterization of prothrombotic disorders  Journal Articles
• Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is ‘shock liver’ the unrecognized provocateur of ischemic limb necrosis?  Journal Articles
• Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw  Journal Articles
• Suboptimal effect of a three‐factor prothrombin complex concentrate (Profilnine‐SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose  Journal Articles
• Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates  Journal Articles
• The Canadian Hemophilia Registry as the basis for a national system for monitoring the use of factor concentrates  Journal Articles
• The Coagulation System in Humans  Journal Articles
• The fibrinolytic system in newborns and children.  Journal Articles
• The platelet aggregating factor(s) of thrombotic thrombocytopenic purpura.  Journal Articles
• The role of leukocytes in thrombosis  Journal Articles
• The status of new anticoagulants  Journal Articles
• Thrombin Generation in Newborn Plasma Is Critically Dependent on the Concentration of Prothrombin  Journal Articles
• Thrombin Regulation in Mother and Fetus During Pregnancy  Journal Articles
• Thrombin activation rate constant: One-stage chromogenic assay for the extrinsic system  Journal Articles
• Thrombin and Antithrombotics  Journal Articles
• Thrombin generation in vitro in the presence of by‐passing agents in siblings with severe haemophilia A  Journal Articles
• Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes  Journal Articles
• Thrombin structure and function  Journal Articles
• Thromboepidemiology: Identifying patients with heritable risk for thrombin-mediated thromboembolic events  Journal Articles
• Thrombosis in children with acute lymphoblastic leukemia  Journal Articles
• Trends in the utilization and wastage of coagulation factor concentrates: the application of a regional tracking programme  Journal Articles
• Unraveling von Willebrand factor deficiency  Journal Articles
• Using pharmacokinetics to individualize hemophilia therapy  Journal Articles
• Venous Limb Gangrene during Warfarin Treatment of Cancer-Associated Deep Venous Thrombosis  Journal Articles
• Vitamin K antagonist reversal strategies: Systematic review and network meta‐analysis from the AABB  Journal Articles
• Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome  Journal Articles
• Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method  Journal Articles
• [New preparations for coagulation disorders].  Journal Articles